Related references
Note: Only part of the references are listed.Molecular Dynamics Study of Oxidized Lipid Bilayers in NaCl Solution
Viwan Jarerattanachat et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides
Janine Schwamb et al.
BLOOD (2012)
Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase
Yu Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Paraoxonase 2 Deficiency Alters Mitochondrial Function and Exacerbates the Development of Atherosclerosis
Asokan Devarajan et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells
I. Witte et al.
CELL DEATH & DISEASE (2011)
Paraoxonase 2 is down-regulated by the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone and attenuates oxidative stress induced by pyocyanin
Sven Horke et al.
BIOCHEMICAL JOURNAL (2010)
One Enzyme, Two Functions PON2 PREVENTS MITOCHONDRIAL SUPEROXIDE FORMATION AND APOPTOSIS INDEPENDENT FROM ITS LACTONASE ACTIVITY
Sebastian Altenhoefer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Oxidative damage increases intracellular free calcium [Ca2+]i concentration in human erythrocytes incubated with lead
M. A. Quintanar-Escorza et al.
TOXICOLOGY IN VITRO (2010)
Paraoxonase: A multifaceted biomolecule
Binita Goswami et al.
CLINICA CHIMICA ACTA (2009)
Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1
Mira Rosenblat et al.
JOURNAL OF LIPID RESEARCH (2009)
Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia
Dominic S. Ng et al.
CARDIOVASCULAR PATHOLOGY (2008)
Exercise-induced oxidative stress: Cellular mechanisms and impact on muscle force production
Scott K. Powers et al.
PHYSIOLOGICAL REVIEWS (2008)
Lipid peroxidation, total antioxidant status, and total thiol levels predict overall survival in patients with oral squamous cell carcinoma
Beena P. Patel et al.
INTEGRATIVE CANCER THERAPIES (2007)
Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats
Emile Levy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation
Sven Horke et al.
CIRCULATION (2007)
Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips
Juri Rappsilber et al.
NATURE PROTOCOLS (2007)
Oxidant stress and B vitamins status in patients with non-small cell lung cancer
Shih-Ming Tsao et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2007)
Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins - Anti-atherogenic role for paraoxonase-2
Carey J. Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Enrichment of integral membrane proteins from small amounts of brain tissue
J. Schindler et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Association between lipid peroxidation and inflammation in obstructive sleep apnoea
K. Minoguchi et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome
Bharti Mackness et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease
Wolfgang Voelkel et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration
Erik S. Musiek et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling
SG Rhee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development
A Ravandi et al.
LIPIDS (2004)
Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH
JF Teiber et al.
JOURNAL OF LIPID RESEARCH (2004)
A lipid peroxidation-derived inflammatory mediator - Identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages
T Kumagai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development
M Aviram et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates
EI Waddington et al.
ATHEROSCLEROSIS (2003)
Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein
CJ Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation
DI Draganov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Cyclopentenone prostaglandins as potential inducers of phase II detoxification enzymes -: 15-deoxy-Δ12,14-prostaglandin J2-induced expression of glutathione S-transferases
Y Kawamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
